Quynh-ThuXuanLeMDFASTRO

Clinical Trials

• S0004: Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Limited-stage Small Cell Lung Cancer Start of enrollment: 2000 Oct 01

  Completed

  Phase 1

• Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer Start of enrollment: 2003 Sep 01

  Completed

  Phase 2

• Cisplatin and ZD1839 + Re-Irradiation in Recurrent Squamous Cell Cancer of the Head and Neck Start of enrollment: 2002 Jun 01

  Completed

  Phase 1

• Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers Start of enrollment: 2000 Sep 01

  Completed

• A Longitudinal Study of Plasma EBV DNA in Nasopharyngeal Carcinoma From Both Endemic and Non-Endemic Patient Populations Start of enrollment: 2001 Nov 01

  Completed

• Treatment Outcomes and Quality of Life After IMRT Treatments of Head and Neck Cancers Start of enrollment: 2003 Apr 01

  Completed

• The Role of FDG PET in Radiation Treatment Planning for Head and Neck Cancers Start of enrollment: 2003 May 01

  Completed

• Indirect Magnetic Resonance Lymphangiography of the Head and Neck Region Using Conventional Gadolinium-based Contrast Start of enrollment: 2003 Feb 01

  Completed

  Not Applicable

• Identification and Characterization of Novel Proteins and Genes in Head and Neck Cancer Start of enrollment: 2002 Apr 02

  Recruiting

• Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy Start of enrollment: 2002 Jan 01

  Recruiting

• Lapatinib and Radiation for Stage III-IV Head and Neck Cancer Patients Who Cannot Tolerate Concurrent Chemotherapy Start of enrollment: 2007 Jul 01

  Terminated

  Phase 2

• Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers Start of enrollment: 1998 Sep 01

  Recruiting

• Real-Time kV Imaging vs. Real-Time 3D Patient Surface Tracking for Head & Neck Cancer Start of enrollment: 2009 Oct 01

  Terminated

  Not Applicable

• Imaging and Biomarkers of Hypoxia in Solid Tumors Start of enrollment: 2010 Dec 01

  Terminated

  Phase 1

• Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers Start of enrollment: 2010 Aug 01

  Completed

  Phase 1

• Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer Start of enrollment: 2013 Mar 22

  Recruiting

  Phase 2, Phase 3

• Human Salivary Gland Disposition of Alda-341 in Patients Undergoing Salivary Gland Surgery Start of enrollment: 2016 Feb 01

  Completed

  Early Phase 1

• Join now to see all